A detailed history of Ever Source Wealth Advisors, LLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 680 shares of HCM stock, worth $13,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares
680
Previous 86 690.7%
Holding current value
$13,294
Previous $1,000 1000.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$16.36 - $21.78 $9,717 - $12,937
594 Added 690.7%
680 $11,000
Q1 2024

Jun 11, 2024

BUY
$12.08 - $18.56 $169 - $259
14 Added 19.44%
86 $1,000
Q4 2023

Feb 09, 2024

SELL
$16.25 - $20.23 $552 - $687
-34 Reduced 32.08%
72 $1,000
Q3 2023

Nov 03, 2023

BUY
$11.85 - $16.95 $1,256 - $1,796
106 New
106 $1,000
Q1 2022

May 25, 2022

SELL
$15.52 - $35.65 $1,489 - $3,422
-96 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$28.89 - $35.33 $2,773 - $3,391
96 New
96 $3,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.38B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.